INFORMing Patients With Oximetry Data to Improve MAD Engagement
← catalyst calendarNCT07564310 · readout in 104 d
Sponsored by ResMed (industry) · RMD — their whole pipeline →.
Phase
Phase 4
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
120estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-06-01 | estimated | When the study began enrolling |
| Primary completion | 2026-12-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-05-01 | estimated | The whole study's end, after follow-up |
| First posted | 2026-05-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Obstructive Sleep Apnea (OSA)
Interventions
- Device: Narval MRD device
- Device: MyNarval intervention (Narval CC MAD + O2 ring + MyNarval smartphone application),
Primary outcome
what the primary-completion date above is the date OFMean overall patient reported experience measure (PREM) questionnaire score
measured 1 month
Permalink · RMD's whole pipeline · Catalyst calendar · Every registered study · What changed